KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer

BACKGROUND: We evaluated KRAS (mKRAS (mutant KRAS)) and BRAF (mBRAF (mutant BRAF)) mutations to determine their prognostic potential in assessing patients with colorectal cancer (CRC) for lung metastasectomy. METHODS: Data were reviewed from 180 patients with a diagnosis of CRC who underwent a lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Renaud, S, Romain, B, Falcoz, P-E, Olland, A, Santelmo, N, Brigand, C, Rohr, S, Guenot, D, Massard, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333487/
https://www.ncbi.nlm.nih.gov/pubmed/25688918
http://dx.doi.org/10.1038/bjc.2014.499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333487/
https://www.ncbi.nlm.nih.gov/pubmed/25688918
http://dx.doi.org/10.1038/bjc.2014.499

Ejemplares similares